Skip to main content

Table 5 Results of sensitivity analysis on the economic cost per IPTi dose delivered. Figures are United States cents, year 2005 (Tsh1205 = US$1)

From: From strategy development to routine implementation: the cost of Intermittent Preventive Treatment in Infants for malaria control

Variables Financial Opportunity Economic cost (Total)
Base case results 17.68 5.11 22.79
Low EPI coverage (71% nationwide) 23.41 6.76 30.18
Exclude sensitization at community level 16.92 4.00 20.9
Use of local brand SP Drug 8.44 4.85 13.29
Increase in salaries and per diem 20.97 5.74 26.71
Using generic drug, increasing salaries, excluding sensitization and lower EPI coverage 22.40 5.28 27.68